Big Pharma Partnership, page-4

Yes. I think a lot of people trading in the Australian/New Zealand market simply don't understand what a Phase 3-ready drug like this is worth. Honestly I think many are clueless.

This company trades at a $30 million USD market cap right now. I am not kidding, that is a monumental, almost unimaginable, undervaluation. I can't express this enough. The company is worth 10 times that on the low side. Let's see, the only preventative food and waterborne GI-illness drug, DoD thinks it may be the key to a Shigella vaccine (evidence backs this up), every person without exception believes Traelan is extraordinarily effective, (sales increasing 150% YoY in USA and just started), Arun Sanyal thinks IMM-124E has a huge role to play in treating NASH, so does NIH (two 100% funded PNAFLD & ASH Phase 2 trials), a Phase 2 C.Diff. readout coming our way, goes on and on and on.

The company and its 3.53 million shares is worth between $100-$300 USD. I said it. Think what you may. Let's see how this plays out.